Back to EP Wealth Advisors, LLC EP Wealth Advisors, LLC

PDSB

9 quarters

Position history for EP Wealth Advisors, LLCEP Wealth Advisors, LLC's holdings in PDS Biotechnology Corporation

No. EP Wealth Advisors exited its PDSB (PDS Biotechnology) position in Q3 2024. Its Q2 2024 13F listed 10,207 shares worth $29,907. EP Wealth Advisors first reported PDSB in Q3 2022 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$30,000

Total Shares Change

-10,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$3.82
0
2024-Q2
Unchanged
10,207
0.0%
$29,9070.0%$2.93
0
2024-Q1
Unchanged
10,207
0.0%
$40,4200.0%$3.96
0
2023-Q4
Unchanged
10,207
0.0%
$50,7290.0%$4.97
0
2023-Q3
New
10,207
-
$51,5450.0%$5.05
28
2023-Q2
Exited
0
-100.0%
$00.0%$5.03
0
2023-Q1
Increased
38,337
+275.6%
$2.9M0.1%$6.15
42
2022-Q4
Increased
10,207
+2.1%
$134,7320.0%$13.20
23
2022-Q3
New
10,000
-
$30,0000.0%$2.97
27

Other major holders of PDSB: BlackRock Finance, Inc., Two Sigma Advisers, LP, Two Sigma Investments, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used